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Drug dependence is a far-reaching problem that goes beyond the 
individual to society at large. While a myriad of substances have addictive 
properties, the scope of this review is limited to crack cocaine – how the brain, 
specifically the mesolimbic dopamine system, is compromised by administration 
of crack cocaine, physiological changes and the relevance of dopamine levels to 
susceptibility to addiction. 
Studies based on the use of behavior analysis tools including functional 
analysis, positive and negative reinforcement, delayed discounting, contingency 
management, stages of readiness, motivation for change, and determining 
alternate behaviors as replacements for addictive behavior are included. 
Participants in the primary studies were cocaine abusers who were attending 
community treatment centers. Inclusion criteria varied by study but most required 
a clean or negative urine result prior to the start of the study as well as an 
assessment to determine extent of drug use and other baseline measurements.  
The use of behavior analysis in providing treatment options is a viable alternative 
for crack addicted individuals as shown by studies presented in this review. 
Offering addiction professionals effective treatment programs such as 
contingency management using voucher programs is viable but only if 
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communities are willing to provide the resources necessary to make these 
alternative treatments available to paying and nonpaying clients.  
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CHAPTER 1 
INTRODUCTION 
 
What is an addiction? What is the difference between substance abuse 
and substance addiction? Why is an addiction so difficult to stop? What factors, if 
any, come into play with addiction? Is addiction a disease or a learned behavior?  
There are so many questions surrounding addiction, many of which are left 
unanswered or answered without adequate scientific evidence, to the detriment 
of the individuals struggling with a life-altering addiction. 
To cover the myriad of substances abused by individuals would be beyond 
the scope of this paper. Instead the focus is to address addiction to one illicit 
substance, specifically crack cocaine. While similarities exist between various 
substances, whether licit or illicit, and individuals may have more than one 
addiction, for example to nicotine and alcohol in addition to crack cocaine, crack 
cocaine is of particular interest due to its highly addictive properties.  
Addiction Defined 
 Addiction or dependence on a drug is a chronic disorder 
characterized by compulsive behavior to find and take the drug, loss of control to 
limit intake of the drug, and emergence of a “negative emotional state” such as 
anxiety or depression when the drug is unavailable (Koob, 2006, p. 25).   
Progression from abuse to dependence does not always occur. Individuals may 
never progress beyond risky consumption while others may go back and forth 
between abstinence, excessive use and dependence. (Substance Abuse and 
Mental Health Services Administration, 1999).  
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 Miller and Carroll (2006) identified variables that contribute to drug 
abuse. These include “elevated rates of family discord, violence, health 
problems, unemployment, poverty and financial problems, homelessness, crime, 
injury, child behavior problems, child abuse and neglect, disability and a host of 
psychological and mood problems” (Miller & Carroll, 2006, pp. 208-209). The 
authors also recognized the pattern that leads to drug dependence. “No one sets 
out to become addicted to drugs. It happens gradually, beginning with initial 
experimentation, moving on to more frequent use, and so on (Miller & Carroll, 
2006, p. 296). “There is no clear moment when a person ‘becomes’ dependent or 
addicted. Instead, dependence emerges over time as the person’s life becomes 
increasingly centered on drug use. The diagnostic criteria for classifying people 
with ‘drug abuse’ and ‘drug dependence’ represent arbitrary cut points along a 
gradual continuum (Miller & Carroll, 2006, p. 296). 
 There are a host of variables that lend themselves to a propensity 
for addiction. Heredity, environment, including family and peers, cultural norms, 
gender, and age are part of the mix that may play a part in an individual’s ability 
to avoid becoming dependent on drugs or they may stack the deck against the 
individual, making them more susceptible to the addictive properties of drugs. 
These variables may be referenced in this discussion but are for the most part 
beyond the scope of this review. 
Properties of Crack Cocaine 
 One of the most potent stimulants, cocaine originates from coca 
leaves which are grown primarily in the South American countries of Peru, 
Ecuador and Columbia. The coca leaves have been smoked by the indigenous 
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people of these countries to alleviate the adversities of living at high altitudes and 
to reduce fatigue (Kinsey et al., 2009).  
As early as the 1880s, cocaine was used for medicinal purposes when it 
was used as an anesthetic for eye, throat and nose surgeries to eliminate pain 
and to constrict blood vessels to control bleeding. The powdered, hydrochloride 
salt form of the drug can be snorted or dissolved in water and injected. When 
snorted, cocaine powder is inhaled through the nose where it is absorbed into the 
bloodstream through the nasal tissues. When injected, a needle is used to 
release the drug directly into the bloodstream. Smoking involves inhaling cocaine 
vapor or smoke into the lungs where absorption into the bloodstream is as rapid 
as by injection. (Office of National Drug Control Policy, 2008).  
Approximately 100 years after powder cocaine was first used, a derivative 
became the drug of choice for many individuals in the 1980s and 1990s because 
it was easy to obtain and relatively inexpensive to buy. The derivative was crack 
cocaine, an addictive stimulant more powerful than cocaine in powdered form. 
“Crack is cocaine that has been processed from cocaine hydrochloride to a free 
base for smoking. It is processed with ammonia or sodium bicarbonate (baking 
soda) and water. It is then heated to remove the hydrochloride, producing a form 
of cocaine that can be smoked. This form of cocaine comes in a rock crystal that 
can be heated and its vapors smoked. The term ‘crack’ comes from the crackling 
sound made when it is heated” (Office of National Drug Control Policy, 2008).  
The intensity and duration of crack cocaine’s effects, including increased 
energy, reduced fatigue, and mental alertness is heightened the faster the drug is 
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absorbed into the bloodstream and delivered to the brain. Inhaling crack cocaine 
vapors produces a quicker, stronger high than snorting or smoking. For the crack 
user, that’s good news and bad news:  a stronger high results but the faster 
absorption means a shorter high – the high from snorting cocaine may last 15 to 
30 minutes but the high from smoking crack may last only five to 10 minutes. In 
order to sustain the high, a crack cocaine user has to smoke the drug again, 
which often results in binges or taking the drug repeatedly within a relatively short 
period of time, at increasingly higher doses (National Institute on Drug Abuse, 
2010).  
By The Numbers 
According to the 2008 National Survey on Drug Use and Health (NSDUH), 
approximately 8.4 million Americans aged 12 or older (representing 3.4% of this 
population) reported trying crack cocaine at least once during their lifetimes. 
Additional 2008 NSDUH data indicated that approximately 1.1 million Americans 
aged 12 or older (0.4% of this population) reported past year crack cocaine use 
and 359,000 of Americans aged 12 or older (0.1% of this population) reported 
crack cocaine use within the past month of when the survey was conducted 
(Office of National Drug Control Policy, 2008).  
The NSDUH estimated that in 2007 there were 2.1 million current (past-
month) cocaine users. Adults aged 18 to 25 years have a higher rate of current 
cocaine use than any other age group, with 1.7% of young adults reporting past-
month cocaine use. Overall, men report higher rates of current cocaine use than 
women. Ethnic and racial differences also occur with the highest rates in those 
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reporting two or more races (1.1%), followed by Hispanics (1.0 %), Whites (0.9 
%), and African-Americans (0.8 %) (National Institute on Drug Abuse, 2010). 
The 2008 Monitoring the Future survey, which annually surveys teen 
attitudes and drug use, reports that while there has been a significant decline in 
the 30-day prevalence of powder cocaine use among 8th-, 10th-, and 12th-
graders from its peak use in the late 1990s, there was no significant change in 
current cocaine use from 2001 to 2008; however, crack use declined significantly 
during this timeframe among 8th- and 12th-graders (National Institute on Drug 
Abuse, 2010). 
In 2007, according to the NSDUH, nearly 1.6 million Americans met 
Diagnostic and Statistical Manual of Mental Disorders criteria for dependence or 
abuse of cocaine (in any form) in the past 12 months. Data from the 2005 Drug 
Abuse Warning Network (DAWN) report showed that cocaine was involved in 
448,481 of the total 1,449,154 visits to emergency departments for drug misuse 
or abuse. Therefore, almost one in three drug misuse or abuse emergency 
department visits (31%) involved cocaine (Office of National Drug Control Policy, 
2008). 
According to the Office of National Drug Control Policy (2010), during 
2004 cocaine was the primary drug involved in federal drug arrests. “There were 
12,166 federal drug arrests for cocaine in 2004. The Drug Enforcement Agency 
made 7,082 arrests for powder cocaine and 3,921 arrests for crack cocaine 
during 2004. During FY 2008, there were 6,168 federal defendants sentenced for 
crack cocaine-related charges in U.S. courts. Approximately 95.9% of these 
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cases involved crack cocaine trafficking. Approximately 0.5% of the crack 
cocaine cases involved simple possession (Office of National Drug Control 
Policy, 2008). 
An article in the March 3, 2008, issue of Newsweek discussed the impact 
of governmental programs such as the War on Drugs initiated by President 
Richard Nixon in 1971 and the creation of the Drug Enforcement Administration 
in 1973 on the criminalization of drug use. “Between 2000 and 2006, the number 
of drug offenders in federal prison jumped 26%, to 93,751. An additional 250,000 
are incarcerated in state facilities and thousands more sit in local jail cells. This 
year the government has budgeted close to $13 billion for drug control, treatment 
and prevention” (Kalb, Newsweek, 2008, p. 41). That $13 billion budget was 
broken down with $8.3 billion going toward stopping drug flow into the United 
States and enforcement of drug laws and $4.6 billion devoted to treatment and 
prevention programs (Kalb, 2008). 
Physical Ramifications 
Crack cocaine is typically smoked through a simple glass pipe. The drug 
reaches the brain within seconds, with the amount of crack controlled by the 
depth of the smoke inhalation and frequency of the puffing. The effect of the drug 
is an extremely euphoric feeling – an intense pleasurable sensation from the high 
or rush. The state of euphoria intensifies normal pleasures, “a release of social 
inhibitions, talkativeness, and an unrealistic feeling of cleverness, great 
competence, and power” (Goldstein, 1994, p. 182).  With sexual feelings 
heightened, crack users may engage in risky behavior such as unprotected sex 
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or sex in exchange for the drug, resulting in increased exposure to sexually 
transmitted diseases, including AIDS (Goldstein, 1994). 
With crack cocaine, a rapid tolerance develops even before drug 
concentration in the blood dissipates. Binge use may result as the user tries to 
keep the high going. Binges may lead to psychotic behavior, including extreme 
paranoia, visual and auditory hallucinations and sensory sensations such as 
bugs crawling under the skin. A binge typically lasts 24-hours or longer, followed 
by a state of depression when the drug supply is depleted. Without the drug, 
cravings for the drug become so intense that seeking the drug becomes all 
important, to the detriment of everything else – family, job, food, hygiene, sleep 
and rational behavior (Goldstein, 1994). 
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CHAPTER 2 
THE BRAIN’S ROLE IN ADDICTION	
Humans are hard wired to seek natural reinforcement from food, water, 
sex, and social interaction for survival and propagation of the species. The 
changes that take place within the brain, specifically the mesocorticolimbic 
dopamine system, are the focus of ongoing research into the critical role this 
system plays in supplying positive reinforcement from drugs. By understanding 
how the brain functions when crack cocaine is used/abused provides an integral 
piece of the addiction puzzle. 
Anatomy of the Addicted Brain 
The mesolimbic dopamine system in the brain is comprised of the ventral 
tegmental area, the basal forebrain, which consists of the nucleus accumbens, 
olfactory tuberal, amygdala, and frontal and limbic cortices, and the dopaminergic 
connection between the ventral tegmental area and the basal forebrain (Koob, 
2006). This system, also called the reward system, “mediates biologic appetites 
such as hunger, thirst and sexual drive” (Floyd & Seale, 2002, p.31). These 
appetites are “located at a rudimentary level in the brain. They are operating in 
neuronal systems well below the cerebral cortex and conscious thought” (Floyd & 
Seale, 2002, p. 31).  Neurons of this system “with cell bodies in the ventral 
tegmental area and synapses in the nucleus accumbens, are primarily 
dopaminergic” (Floyd & Seale, 2002, p.31). 
The process of communication between brain cells is explained by 
Shuman, National Institute on Drug Abuse (NIDA Notes, 2007):  
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“The task in neurotransmission is to convey a signal from a 
sending cell to a receiving cell across an open space known as a 
synapse. All brain cells accomplish this in approximately the same 
way. 
The sending cell manufactures neurotransmitter molecules 
and stores them in packets called vesicles. When stimulated 
appropriately, the cell generates an electric signal and causes 
some vesicles to migrate to the cell membrane, merge with it, open 
up, and release their contents into the synapse. Some molecules 
drift across the synapse and link up, lock-and-key fashion, with 
molecules called receptors on the surface of the receiving cell. 
Receptors bridge the receiving cell’s membrane; they have one 
facet on the outside and one on the inside of the cell. When the 
neurotransmitter links up with the exterior facet, the interior facet 
precipitates an electrical response in the cell membrane or inside 
the cell. The result may be increased production of some cell 
product or—often—a repeat of the process just described, so that 
the message gets relayed in turn to the next cell in the circuit. 
At this point, cell-to-cell communication is complete. The 
neurotransmitter molecules drop off the receptors. Loose again in 
the synapse, they meet three fates: 
 Some attach to another receptor; 
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 Some encounter an enzyme, a chemical that breaks 
them apart; and 
 Some reenter the sending cell via a special pathway 
through the axon membrane, called a transporter.  
Once back inside the cell, they are available for re-release in 
future neurotransmission episodes. 
Normally, when drugs are not present, the cycle of release, 
breakup, and cell re-entry maintains the amount of neurotransmitter 
in the synapse, and hence neurotransmission, within certain limits. 
In most cases, when an abused drug enters the brain, it causes 
neurotransmission to increase or decrease dramatically beyond 
these limits” (NIDA Notes, 2007). 
An important finding regarding dopamine, a neurotransmitter located in the 
nucleus accumbens, was established by Nader through research he and his 
associates conducted with rhesus monkeys at Wake Forest University. Nader 
found that “cocaine lowers availability of the dopamine D2 receptors in the basal 
ganglia—the brain region that includes key components of the reward system. 
The consequences may include addiction-promoting alterations in cognitive 
functioning and decision making” (NIDA, 2009). 
The study confirmed that animals with lower D2 receptor availability were 
especially responsive to cocaine's reinforcing effects. An explanation of a D2 
receptor was provided by Childress: “Cocaine-addicted adults with long histories 
of addiction had low numbers of dopamine (type ‘D2’) receptors in the striatum (a 
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critical way station in the reward circuitry), as compared with controls who had no 
history of any substance abuse (Childress, 2006, p. 51). This finding is important 
for people trying to recover from cocaine addiction because receptor availability 
levels in some of the monkeys used in Nader’s research recovered after less 
than one year after being removed from cocaine administration.  Nader 
“measured the monkeys’ D2 receptor availability before cocaine exposure by 
injecting each animal with a radiotracer that bound to the receptors. The 
radiotracer competed with dopamine for the receptor and provided a measure of 
D2 function. Over the course of a three-hour brain imaging study, the scientists 
used positron emission tomography (PET) to visualize and quantify the bound 
radiotracer” (NIDA, 2009).  
The monkeys were allowed to self-administer cocaine in an “experimental 
chamber equipped with two levers—one that delivered banana pellets during the 
first 20 minutes of the test and another that provided the animal with an infusion 
of cocaine during the next 60 minutes. Then, the researchers put the animals 
through this sequence a second time. To describe the neurobiological effects of 
chronic cocaine exposure, the investigators continued the self-administration 
experiments and measured D2 receptor availability for a year” (NIDA, 2009). 
The monkeys whose PET scans revealed lower D2 receptor availability at 
baseline testing before their initial cocaine exposure, self-administered cocaine at 
higher rates. “This finding suggests that lower D2 receptor availability increases 
sensitivity to cocaine reward” (NIDA, 2009). PET scans administered after five 
days of self-administration of cocaine showed that the monkeys’ available 
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receptors had dropped by 15%, on average. What was significant was that three 
monkeys that were allowed to self-administer the drug for only one week, D2 
receptor availability returned to baseline values by the third week of abstinence 
(NIDA, 2009). 
Of particular importance was the inability of two of the monkeys in Nader’s 
study to recover D2 receptor availability following year-long cocaine self-
administration. While these monkeys were self-administrating cocaine, they 
exhibited a reduced attraction to food. While the monkeys were able to press a 
lever for food, they did so only half as often as the monkeys whose receptors 
returned to baseline after long-term cocaine self-administration. According to 
Nader, “Although the findings are preliminary, we believe that these individuals 
may find rewards other than cocaine devalued. If it is not cocaine, it is just not 
rewarding to them” (NIDA, 2009).  
 Childress (2006) agreed that low D2 dopamine receptors influence 
vulnerability to addiction. Brain-imaging showed that cocaine-addicted adults, 
who reported long-term cocaine abuse, actually had low numbers of type D2 
receptors. Childress noted that the finding goes against what was expected – 
that addicted individuals would have more dopamine receptors and would 
experience a greater (positive) drug effect and might become more easily 
addicted. Other research cited by Childress found that people in the control 
group (no addictions), who responded positively to an “infusion of the stimulant 
methlphenidate” (Childress, 2006, p. 51), had D2  receptors that were at levels as 
low as cocaine addicts who had abused cocaine for many years. The same study 
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found that individuals with normal levels of D2 receptors found the stimulant too 
powerful and unpleasant. This finding suggests that a higher D2 receptor level 
may actually protect an individual from becoming drug dependent (Childress, 
2006). 
 The firing of dopamine cells by the introduction of drug conditioned 
cues was studied by Goldstein, Tomasi, Alia-Klein, Carrillo, Maloney, Woicik, 
Want, Telang and Volkow (2009). By introducing drug-related and neutral words 
to cocaine-addicted individuals and controls, researchers hypothesized that the 
drug-related words would trigger activation in the mesencephalon, the area of the 
brain where dopaminergic cells are found in the cocaine addicted subjects. Using 
functional magnetic resonance imaging or fMRI, researchers demonstrated that 
drug-related words activated the mesencephalon in the cocaine addicted 
individuals.  
 Fifteen individuals with cocaine use disorders and 15 control 
participants, matched on sex, age, education, and general intellectual 
functioning, completed screening and gave written informed consent to 
participate. Participants were scanned during a drug word fMRI task while 
viewing drug or neutral words. 
 Using repeated measures ANOVA with verbal fluency showed 
group by word interaction (p<0.01). Post hoc t tests showed that the interaction 
was explained by higher drug than neutral responses in the cocaine users 
(p<0.05) but not in healthy participants, where a trend toward the reverse pattern 
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was shown and a significant difference was shown between the study groups for 
the drug words only (drug: p<0.05; neutral: p>0.3) (Goldstein et al. 2009).  
 For the first time, it was shown that drug words defined as “uniquely 
human learned verbal descriptors of stimuli” (Goldstein et al., 2009, p. 6004), 
increased fMRI responses in the mesencephalon, “a major source of 
dopaminergic release to motivationally salient or conditioned stimuli in cocaine 
addicted individuals” (Goldstein et al., 2009, p. 6004). According to the authors, 
“Our results for the first time demonstrate that, in addicted individuals, drug 
words alone can elicit an fMRI-BOLD (blood oxygenation level dependent) 
mesencephalic response, as possibly associated with 
dopaminergic…mechanisms…that are crucial to conditioning” (Goldstein et al., 
2009, p. 6005). The authors concluded that the ease of administration of the brief 
verbal fluency test and fMRI cue reactivity “could be used as a biomarker of 
neurobiological changes in drug addiction” (Goldstein et al. 2009, p.6005).  
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CHAPTER 3 
BEHAVIOR ANALYSIS: TOOLS FOR CHANGE 
 
As important as brain research is to addiction, without the associated 
behavior – learning to use the drug, seeking the drug, buying the drug, 
administering the drug, avoiding discovery – the research would be moot. In 
other words, the brain does not operate alone. Without learning addictive 
behaviors, individuals would receive a high from the brain’s naturally occurring 
release of neurotransmitters, such as dopamine, after a satisfying meal, looking 
at a beautiful work of art or after a sexual experience.  
An individual does not inherently know how to “do drugs.” He or she must 
learn the nuances of using drugs. White (1996) described a “culture of addiction” 
that meets the needs of its members that are unmet by society-at-large: 
“The culture of addiction is a way of life, a means of 
organizing one’s daily existence, and a way of viewing people and 
events in the outside world. It is a way of talking, walking dressing, 
gesturing, believing, mating, working/playing, thinking, and seeing 
that separates people who are ‘in the life’ from those who are not. 
The culture of addiction encompasses values, artifacts, places, 
rituals, relationships, symbols, music and art, all of which reinforce 
one’s involvement in excessive drug consumption. 
The culture of addiction can play a role in both initiating and 
sustaining substance abuse disorders” (White, 1996, p. 5). 
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The tools of behavior analysis provide insight into the “why” of addictive 
behavior, as well as approaches that give individuals living a drug dependent 
lifestyle the options to return to a life free of life-altering substances. A key to 
unlocking the “why” of addiction is functional analysis. 
According to Jakes (2001), the origin of functional analysis goes back to 
operant conditioning, and he attributed B.F. Skinner, who used individual 
subjects to look at the “relationship between stimulus and response” (Jakes, 
2001, p. 133) as a psychologist who believed functional analysis “explained how 
the occurrence of certain behaviors was a function of specific stimuli”(Jakes, 
2001, p.133). Jakes explained that the “key aim of a functional analysis was to 
establish the situations in which symptoms or problem behaviors occur, and the 
apparent consequences of these behaviors” (Jakes, 2001, p. 133). 
Jakes (2001) pointed to Wolpe for making functional analysis a clinical tool 
for psychologists and others. It was Wolpe who made the connection between a 
behavior and the individual’s learning history. Using anxiety as an example, 
Wolpe hypothesized that if you understood the learning history of a symptom, 
you would understand the cause of the symptom and thereby help the individual 
by helping he or she unlearn the association (Jakes 2001). 
The National Institute on Drug Abuse website concerning drug treatment, 
noted that every time an individual used cocaine during treatment, the therapist 
and patient should do a functional analysis – “identifying the patient’s thoughts, 
feelings, and circumstances before and after the cocaine use.” The NIDA states 
that “early in treatment, the functional analysis plays a critical role in helping the 
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patient and therapist assess the determinants, or high-risk situations, that are 
likely to lead to cocaine use and provides insights into some of the reasons the 
individual may be using cocaine (e.g., to cope with interpersonal difficulties, to 
experience risk or euphoria not otherwise available in the patient’s life)” (NIDA, 
2010). 
Medical professionals are likely to encounter patients who are exhibiting 
symptoms of addiction.  Bloom and Smith (2001) advocated a functional 
assessment that included a description of the sequence of events before, during, 
and after the problematic behavior, exploration of reinforcements – what needs 
are not being met and what the patient finds pleasurable. In addition, clinicians 
should try to discover what attempts have been made in the past to resolve the 
behavior and to identify “noxious or extinguishing responses” (Bloom & Smith, 
2001, p. 109). 
In a medical setting outside of the office, the medical professional may 
offer referral to crisis counseling, addiction treatment or other services following a 
medical emergency such as an attempted suicide, rape, battery or other crisis. 
Individuals in a state of medical crisis will respond to the health professional’s 
suggestion for follow-up care with a reliable community resource, if there is a 
caring, non-judgmental interaction during the course of treatment (Hoff, 2001).  
One of the problems with functional assessments for crack addicted 
individuals is the inability for direct observation of the undesirable behavior. It 
would be unethical as well as illegal to advocate use of an illicit substance for the 
purpose of observing the events that precede use, the actual using behavior and 
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the resulting aftermath. Functional analysis for crack using individuals must rely 
on indirect functional behavior assessments.   
While family members and others may contribute valuable information 
regarding an individual’s drug use, the primary source of information is most 
often obtained from the individual during the admission process to inpatient and 
outpatient treatment programs.  During the interview process for admission to a 
rehabilitation program, individuals may be under the influence of a substance or 
substances, under duress from parents, spouses or police, or may be in denial 
regarding the degree of their dependence on a substance or substances. At the 
time of the initial interaction, the individual may be facing a crisis situation 
including overdose or suicide ideation, loss of residence, loss of employment, 
loss of one or more relationships, medical emergencies or a legal crisis (Ramsay 
& Newman, 2000). Any or all of these factors may result in unreliable information 
that may be subsequently used as the basis for admission or denial for 
admission to a treatment program. 
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CHAPTER 4 
UNDERSTANDING POSITIVE REINFORCEMENT/NEGATIVE 
REINFORCEMENT IN ADDICTION 
 
In behavior analysis terms, positive reinforcement occurs when a behavior 
is “followed immediately by the presentation of a stimulus that increases the 
future frequency of the behavior in similar conditions,” whereas a negative 
reinforcement is a stimulus “whose termination or reduction in intensity functions 
as reinforcement” (Cooper, Heron & Howard, 2007, pp. 700-701).  
With addiction, positive reinforcement may be viewed as euphoria from a 
normal state experienced by the user after self-administration of a drug, which is 
quickly followed by negative reinforcement – the need to take more of the drug to 
relieve the effects of withdrawal and the loss of the euphoric state. Both positive 
and negative reinforcement are believed to be contributing factors to the 
addictive properties of drugs. Wise (1988) proposed that positive and negative 
reinforcers could be scientifically distinguished by the various parts of the brain 
they activate. 
A psychomotor stimulant theory of addiction, according to Wise (1988), 
grew out of research on biological mechanisms of drive and reinforcement. “It is 
an extension of the view that positive reinforcers are stimuli that elicit a variety of 
species-typical, biologically primitive reactions, including eating, drinking, 
copulation, nest building, etc.”(Wise, 1988, p.119).  These types of positive 
reinforcers are called forward locomotion, which Wise reported was first studied 
by Schneirla in 1959 and correlated with brain stimulation reinforcement by 
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Glickman and Schiff in 1967. Wise proposed an empirical study to determine if 
positive and negative reinforcers could be separated by the areas in the brain 
they activate (Wise 1988). 
The summarization of numerous research studies on brain stimulation 
reinforcement, amphetamine and cocaine reinforcement, opiate reinforcement, 
food and water reinforcement, the “motor” – “psychomotor” distinction, and brain 
mechanisms of negative reinforcement by Wise (1988) provide insight into 
complex theories regarding brain function and the relationship to addiction. Of 
particular interest is the section Wise (1988) devoted to the implications of these 
research studies, some of which follow: 
 The importance of distinguishing between cravings that result from a 
history of positive reinforcement or from a present condition of negative 
reinforcing potential of the drug. Remembering past positive 
reinforcement is key in initial addiction and relapse after long periods of 
detoxification. 
 Opiates and cocaine activate the same neural circuitry and either will 
cause a return to drug dependence in ex-addicts. Nicotine may be an 
underestimated stimulant to cause relapse. 
 Pharmacological approaches to addiction are ineffective if only used to 
treat withdrawal symptoms of detoxification.  Any dopamine agonist 
should relieve cocaine craving by targeting the same target neurons in 
the same positive reinforcement pathway as cocaine (Wise 1988). 
21 
 
The conclusion that Wise reached is concerning. Wise postulated that if 
the positive reinforcing properties of addictive drugs occur within the physical 
structure of the brain, their reinforcement may be more powerful than naturally 
occurring environmental stimuli such as “nature, art, or music. Whereas the 
signals from natural reinforcers depend on sensory transducers and the 
propagation of nerve impulses across axons and synaptic junctions, drugs can 
activate reinforcement mechanisms centrally, saturating receptor mechanisms 
that may never be saturated as a consequence of natural reinforcement” (Wise, 
1988, p. 127). 
An effect called priming is closely associated with the reinforcing 
properties of addictive drugs. Even after long periods of abstinence, taking even 
a small amount of their drug of choice, can lead to a full-blown relapse. This 
priming effect was the impetus for a study by De Wit and Stewart in the mid-80s, 
which was described by De Wit (1996). After rats were trained to deliver daily 
self-administered cocaine or heroin, they were put on periods of extinction. After 
one or two hours on extinction, rats exhibited no drug seeking behavior. A 
researcher then administered an injection of the self-administered drug, a 
different drug or saline. The rats given injections of cocaine, which was the self-
administered drug, returned to drug seeking behavior for cocaine as was the 
case with rats that self-administered heroin and were given heroin after 
extinction. Heroin given to the cocaine addicted rats did not serve as a priming 
effect nor did cocaine given to the heroin addicted rats, which demonstrated drug 
specificity (de Wit 1996). 
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Conversely, human subjects are many times long-time drug abusers 
whose prior drug using history may affect responses through physiological 
consequences of a drug and/or conditioned or learned effects. In addition, the 
dependent measures with human subjects are frequently self-reports of drug 
craving and use whereas the dependent variables with laboratory animals are 
observed drug seeking and using behaviors (de Wit 1996).   
De Wit (1996) cited numerous research hypotheses for the priming effect 
including classical conditioning, incentive motivation and operant conditioning, all 
of which needed more empirical study.  De Wit (1996) discussed an interesting 
theory by Marlatt that a one-time lapse of a previously abused drug leads to 
increased and ongoing use of the drug due to a sense of failure on the part of the 
addict. De Wit (1996) stated that while this theory is “plausible,” it applies only to 
drug users who are trying to quit their drug use and not to those who are not 
attempting to quit such as social drinkers. Further “systematic parametric” studies 
that investigate “the time course, stability, dose-dependence, context-
dependence and specificity” of the priming effect are necessary, according to De 
Wit, in order to “discover the underlying behavior mechanisms” (de Witt, 1996, 
p.9) of the phenomenon.  
Delayed Discounting in Addiction 
Drug dependence has been shown to cause a phenomenon known as 
delayed discounting – a “foreshortening of time perspective, so that longer term 
delayed rewards are discounted in value” (Miller & Carroll, 2006, p.298). Delayed 
discounting is defined as a “behavioral process that values delayed reinforcers 
less than reinforcers that are not delayed” (Bickel & Potenza, 2006, p. 11). The 
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extent of discounting may be measured by psychosocial procedures where an 
individual chooses between an immediate reinforcer or reward and a delayed 
reinforcer. Bickel and Potenza (2006) provide the following example of delayed 
discounting: “What could provide more specific knowledge regarding the extent 
of discounting is identifying the amount of immediately available money that the 
chooser values approximately the same as delayed money. This information can 
be obtained by progressively decreasing the amount of the immediately available 
money across trials (e.g., $975, $950, $925) and keeping the delayed amount 
unchanged ($1,000), and then identifying the specific monetary amount that 
results in the chooser’s switch from the immediate to the delayed amount” (Bickel 
& Potenza, 2006, p. 11).  The authors added, “A substantial body of literature 
suggests that drug-dependent individuals (alcohol-, cocaine-, heroin-, tobacco-
dependent) discount money substantially more than matched control normals 
and that the drug dependent substantially discount their drug of dependence 
more than an equivalent amount of money” (Bickel & Potenza, 2006, p.12). 
Contingency Management Models 
As discussed previously, finding rewards to replace the powerfully 
addictive properties of crack cocaine and other drugs may seem impossible to 
achieve. One tool that is supported in the addiction literature is the use of 
contingencies in achieving abstinence and other target behaviors such as 
treatment attendance. While contingency management models are not without 
problems, such as a return to substance use upon termination of the use of a 
contingency, the use of contingencies to retain individuals in treatment and 
maintain abstinence results in more positive outcomes in  personal areas such as 
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employment, interpersonal relationships and medical issues and psychological 
functioning show promise(Carroll & Rounsaville, 2006).  
The effect of an alternative reinforcer, such as varying amounts of money 
on the self-administration of smoked cocaine, was a secondary purpose of a 
study undertaken by Hatsukami, Thompson, Pentel, Flygard, and Carroll (1994). 
According to the authors, the primary purpose was to address methodological 
issues associated with using smoked cocaine in a parametric design. Study 
participants, 12 male cocaine abusers, ages 24-41, completed extensive 
medical, legal and psychiatric histories, as well as their histories of drug use. 
Medical examinations, including electrocardiogram, pulmonary function test, 
chest x-ray, urine analysis, and blood chemistry panel were performed on all 
participants. Inclusionary criteria was extensive and required only cocaine and 
nicotine use, history of smoked cocaine use at least twice weekly for the six 
months preceding the study, no psychiatric disorders, no major medical 
problems, a negative test for HIV, no history of violence and a last chemical 
dependence treatment at least 12 months previously (Hatsukami et al., 1994) . 
Subjects stayed for eight days (not concurrently) in an inpatient unit of a 
clinical research center where they were closely monitored by medical personnel 
during the course of the study. Following two pre-experimental days when no 
cocaine was administered, subjects were familiarized with equipment and 
procedures. On the first day of the study, subjects attended four experimental 
sessions. For the first three sessions, they received one of three possible doses 
of cocaine – 5.0 mg, 0.2 mg/kg, or 0.4mg/kg, with “the 5.0 mg considered to be a 
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low dose with minimal subjective and physiological effects” (Hatsukami et al., 
1994, p. 117). Order of the doses was randomized and subjects received only 
one dose per day. During the fourth session, one of the doses was repeated and 
was randomly selected. (Hatsukami et al., 1994). 
An IV catheter was placed in the non-dominant arm of the participant for 
blood monitoring and for IV access in case of emergency. For one hour, baseline 
measurements were recorded, followed by a sample dose of that day’s dose 
size. Participants were given 10 tokens, each worth a specified amount of 
money, and told that they could use the tokens on up to 10 deliveries of a similar 
dose size of cocaine or turn them in for the specified amount of money ($2, $3, 
$5 or $7). The monetary value varied across subjects but not within subjects. 
After 30 minutes, a green light indicated participants could purchase another 
dose of cocaine with a token. Thirty minutes were taken between cocaine 
deliveries. Blood pressure, heart rate and ECGs were recorded at varying 
intervals. Subjects were required to remain seated in the room with the 
procedure repeated until either 10 doses were taken or five and one-half hours 
had elapsed. If no cocaine was administered, readings were not taken of blood 
pressure, etc., until the next cocaine delivery. Unused tokens were turned in for 
money. Tokens could not be used to buy cocaine during other sessions. Money 
was not given out until the end of the study. Following the delivery of cocaine, 
two post-experimental days followed and the same measures were taken as 
during the pre-experimental phase (Hatsukami et al., 1994).  
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The study found that higher doses of cocaine were selected over lower 
doses. Data analysis showed that “if the magnitude of the alternative reinforcer or 
the cost of cocaine was smaller, subjects were more willing to self-administer 
cocaine than if the magnitude of the alternative reinforcer or the cost of cocaine 
was higher” (Hatsukami et al., 1994, p. 123). The authors acknowledged that the 
small number of participants and the varying costs of cocaine and the total 
amount of money available may “temper” the study’s findings (Hatsukami et al., 
1994). 
Katz, Chutuape, Jones, and Sitzer (2002), used an abstinence-contingent 
voucher with heroin addicts who also abused cocaine. Fifty-two opiate-
dependent subjects who recently completed an inpatient detoxification program 
and were enrolled in an outpatient treatment program within seven days of 
inpatient discharge participated in the study. Following consent, subjects 
provided a urine sample, completed an assessment battery and were introduced 
to their counselors. Subjects were grouped by urine sample results, detoxification 
program of referral, and living arrangements and were then randomly assigned to 
either treatment with or treatment without voucher incentives. Twenty-nine 
participants were assigned to the voucher condition; 23 subjects were assigned 
to the no-voucher condition. Both groups were asked to attend the clinic three 
times per week for three months, to submit urine samples under observation and 
participate in cognitive-behavioral counseling. Subjects were not mandated to 
attend either the research component or the counseling sessions (Katz et al., 
2002).  During the next three months of the study, counseling was offered once 
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each week and two group sessions, a Job and a Social Club, were available. The 
Job Club focused on employment skills such as interviewing. Clients participated 
until they became employed. During the Social Club, participants ate lunch and 
interacted with non-drug using peers so long as they were abstinent. Clients 
were provided with bus tokens or parking passes for each counseling session 
they attended. Missing seven consecutive counseling sessions resulted in 
dismissal from the study. Counselors were allowed to give $20 attendance 
vouchers to subjects who had missed up to three sessions as an incentive to 
return to counseling. Attendance incentives were given by mail 51 times during 
the study to 40 subjects – 79% were voucher clients and 74% were no-voucher 
clients. Letters were followed by counseling attendance on 23.5% occasions 
(Katz et al., 2002). 
Vouchers were earned for each urine sample provided that was negative 
for both opiates (heroin) and cocaine. Vouchers were worth a designated 
monetary amount and could be exchanged for goods and services. Subjects 
earned $2.50 for the first opiate- and cocaine-negative urine samples, with the 
value increasing by $1.25 for each successive negative urine sample. For each 
set of three consecutive negative urine samples, clients earned a $10 bonus. 
Missing an appointment or submitting a positive urine sample, resulted in the 
voucher value being reset to $2.50. If the value was reset and the next five 
consecutive urine samples were negative, voucher values were reset to the 
earnings level reached before the reset. To encourage early engagement with 
the study, clients received a one-time $100 bonus for the first three consecutive 
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opiate- and cocaine-negative urine samples. While the three consecutive 
negative urine samples could be done at any time during the study, 73% of the 
earned bonuses were collected during the first three months. For remaining drug 
free throughout the study, a total of $1,087.50 could be earned (Katz et al., 
2002). 
Days in treatment, total number of research visits, total number of 
counseling sessions, number of negative urine samples, longest duration of 
continuous abstinence and percentage of clients with one, two and four weeks of 
continuous abstinence were the measures used to compare outcomes for 
voucher and no-voucher subjects. Clients in the voucher condition earned an 
average of $171 in vouchers; four clients earned no vouchers, 10 earned less 
than $10 in vouchers and 15 clients earned more than $10 in vouchers. Because 
clients were not mandated to attend research visits or counseling sessions, 
retention was calculated as the day of initial intake to day of the last face-to-face 
contact, either research or counseling visit. Mean days in treatment for voucher 
subjects was 35.9 out of a possible 180; 39.3 days for no-voucher subjects. 
Clients in the voucher group submitted, on average, 8.3 opiate- and cocaine-
negative urine samples versus 6.2 opiate- and cocaine-free samples from the no-
voucher group, out of a total possible of 36 samples over the course of the study. 
Groups differed “significantly on intake urine results at study onset: those 
negative at intake made more research visits (M=11.5), submitted significantly 
more negative urine samples (M=9.9) and had significantly longer durations of 
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continuous abstinence (M=19.8). There was no significant interaction between 
intake urine status and voucher incentive condition” (Katz et al., 2002, p. 140). 
Overall results found that a voucher incentive program did not improve 
retention or drug abstinence outcomes for recently detoxified heroin addicts who 
were required to abstain from both heroin and cocaine use to earn vouchers 
during outpatient treatment.  Two voucher incentive programs cited by the 
authors, specifically Downey et al. (2000) and Piotrowski et al. (1999), concluded 
that there was one constant in both studies, which was “some patients never 
contact the reinforcer because they never submit a drug-negative urine. This was 
true for 50% to 50% of clients in the two studies described above but was less of 
a factor in the present study, where 86% of clients submitted at least one 
negative urine sample” (Katz et al., 2002, p. 141).   
The Katz study (Katz et al., 2002), which used subjects with dual-drug 
addictions discussed two possible improvements for future research – allowing 
participants who use more than one drug to stop using one drug at a time and to 
increase the value of the reinforcer to establish greater levels of compliance. The 
authors also cited possible reasons for their study results which included lapse 
and relapse function in heroin versus cocaine users. Recently detoxified heroin 
users may have a harder time in the early stages of abstinence due to the 
severity of withdrawal symptoms compared with participants who experience 
cocaine withdrawal. Another possibility was that the counseling provided in the 
study might have been more effective had it included “outreach efforts designed 
to retain clients in treatment by contacting them in the community when they fail 
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to show up for appointments” (Katz et al., 2002, p. 141). Providing stronger 
attendance incentives and allowing for a more flexible attendance schedule for 
an opiate addicted population may have resulted in stronger outcomes (Katz et 
al., 2002). 
One study (Petry, Alessi, Carroll, Hanson, MacKinon, & Rounsaville, 
2006) used two approaches of prize-based contingency management with 131 
substance abusing outpatients at a community clinic randomly assigned to one of 
three 12-week treatments: standard treatment, standard treatment with 
contingency management for negative urine samples or standard treatment with 
contingency management for completing goal-related activities. A heterogeneous 
patient group consisting of heroin- and cocaine-abusing individuals was used to 
increase the generality of study findings. Following informed consent and 
inclusion criteria (“initiating a treatment episode at the clinic and met past-year 
Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American 
Psychiatric Association, 1994) criteria for cocaine or heroin abuse or dependence 
or evidenced recent use” (Petry et al., 2006, p. 593), a two-hour interview was 
conducted to obtain demographic data, as well as diagnostic status. The 
Addiction Severity Index (ASI) was administered to determine psychosocial 
issues and breath and urine samples were collected to determine alcohol use, 
which would exclude participants from the study. The ASI was repeated at one, 
three (post-treatment), six and nine months after initiation of treatment. Subjects 
received $15 for the one-month evaluation and $30 for the other evaluations. 
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Follow-up rates exceeded 70% in each condition at each interval (Petry et al., 
2006). 
Using a computerized randomization, groups were assigned to balance 
age, gender, ethnicity, whether or not subjects received inpatient treatment prior 
to seeking outpatient treatment, and whether subjects were unemployed, 
employed full time or employed part time. Those assigned to the standard 
intensive outpatient treatment condition participated in group sessions led by 
various clinicians that covered relapse prevention, coping and life skills, 12-step 
treatment and AIDS education for up to four hours each day over five days each 
week for four weeks with gradual reduction in sessions. Breath and urine 
samples were collected three days per week for the first three weeks and two 
days per week during weeks four through six. In addition, to control for  
“individualized attention associated with activity selection in one CM condition, a 
research assistant met with subjects for 15 minutes every week to present 
educational materials on health, alcohol, drugs, AIDS, stress management, 
depression, the law, insomnia, hepatitis, smoking, family, drinking and driving, 
and wellness” (Petry et al., 2006, p. 594). 
With the exception of the individual education sessions, subjects assigned 
to the contingency group that could earn prizes by completing goal-related 
activities received the same treatment, including the collection of breath and 
urine samples, as the subjects assigned to the standard treatment only condition. 
Participants completed a needs assessment during the first week of the study 
that evaluated problems in 10 areas: employment, education, family, housing, 
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medical-psychiatric, legal, sobriety, social-recreational, personal improvement, 
and transportation. Subjects selected two to four goals based on their 
assessments and every week selected three activities to be completed the next 
week in order to meet their long-term goals. Activities were not mandated but all 
participants were encouraged to work on social-recreational and sobriety goals 
(Petry et al., 2006). 
When activities were completed and verified by receipts, brochures or 
other documentation, one draw from a prize bowl was awarded for each 
completed activity. Draws increased by one for every consecutive week that 
three activities were completed. Five bonus draws were also awarded for every 
week that three activities were completed for a total of 294 draws across the 
study’s timeframe. If a participant failed to complete a selected activity, their draw 
was reset to one draw per activity. When all three activities were done, earned 
draws were reset back to the highest number attained prior to the failed 
completion. The prize bowl contained 500 cards with 275 showing “Good job, try 
again” and did not earn a prize. Of the 255 prize cards, 199 were small prizes 
such as $1 fast food vouchers or a bus token, whereas 25 cards were large 
prizes such as movie passes, phone cards, etc., and one card was for the largest 
prize worth $100 in merchandise such as a DVD player or five of the other large 
prizes (Petry et al., 2006). 
In the third condition, subjects received the standard treatment, the 15-
minute education component, breath and urine collections, and instead of 
choosing an activity for the chance to win prizes, participants in this group could 
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win prizes for every negative specimen for heroin, alcohol and cocaine they 
submitted. Petry et al. (2006) noted that positive specimens were most often for 
cocaine use, followed by heroin use and lastly alcohol use. The first submission 
of negative specimens earned one draw from the prize bowl with the number of 
draws increasing by one for every consecutive negative specimen. A five-draw 
bonus was earned each week if all samples were negative. If a participant tested 
positive for any one of the three substances (cocaine, heroin or alcohol) or 
refused to submit a specimen or was a no show, the number of draws went back 
to one. After two consecutive weeks of negative specimens, the number of draws 
was reset to the number earned prior to the above conditions. A total of 291 
draws could be earned for submitting negative specimens for all 21 drops across 
the 12-week study (Petry et al., 2006). 
Findings from the study showed that contingency management led to 
some improvements, however, the contingency management activity condition 
was less effective than the contingency management abstinence condition in 
“retention and some drug abuse outcome measures.” This finding was not in 
keeping with the results of a study conducted by Iguchi et al. (1977) that showed 
“contingency management treatment that reinforced activity completion resulted 
in greater reductions in drug use than a contingency management treatment that 
reinforced abstinence directly” (Petry et al., 2006, p. 599). Several reasons were 
cited by the authors for the difference in findings: 
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 Methadone patients abuse more drugs and therefore have more 
positive specimens during treatment; however, 99% of subjects in this 
study achieved at least one negative sample. 
 Reinforcer type and magnitude varied between the studies (prizes in 
this study and vouchers in the Iguchi study). 
 Activities were more difficult in this study (e.g., creating a resume) and 
may have resulted in overall lower rates of reinforcement. 
 In this study there were few differences between the two contingency 
management conditions based on ASI scores, which may reflect the 
individualized nature of the activity choices. 
 A more comprehensive assessment instrument that allowed for more 
areas of functioning might be more effective. 
 Subjects with an alcohol only assessment were excluded from the 
study; their inclusion may have changed outcomes. 
 Urine samples were collected infrequently, which may not represent 
actual return to drug use. 
 Engagement in targeted behaviors may not correspond directly to drug 
use behavior changes (Petry et al., 2006). 
Strengths of the study as noted by the authors included study design 
which “specifically examined the important issue of target of reinforcement. 
Overall scheduled magnitudes of reinforcement were equated between the two 
contingency management conditions, and amount of time and personal attention 
received by the research assistant were similar in all three conditions. Multiple 
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outcome measures were assessed, and all showed some degree of 
concordance. Reasonable sample sizes were included, and adequate rates of 
follow-up were achieved. The study was conducted in a community-based 
treatment program, with treatment as usual provided to all patients as the 
standard of care” (Petry, et al., 2006). 
Another study (Schmitz, Lindsay, Stotts, Green & Moeller, 2010) reviewed 
the effectiveness of Levodopa, a dopamine precursor, versus a placebo, and its 
effectiveness when combined with contingency management conditions that 
targeted these behaviors: attendance, medication compliance, and cocaine 
abstinence. The initial protocol demonstrated the effectiveness of levodopa 
treatments versus placebo that included abstinence-based contingency 
management. The second arm of the study was run concurrently in 2008 and 
examined levodopa treatment effects across different contingency management 
conditions. One hundred one subjects dependent on cocaine and seeking 
treatment  met inclusion criteria to participate in a 12-week, randomized, 
placebo-controlled trial of levodopa. Subjects provided medical histories and 
received a physical examination as well as laboratory tests for liver and thyroid 
function and a cardiac evaluation. Blood pressure, heart rate and weight were 
obtained each week. The Structured Clinical Interview and the Addiction Severity 
Index were administered prior to the study. In the CM (contingency 
management)-URINE condition, subjects were given vouchers worth cash 
amounts for urine drops that were negative for cocaine; in the CM-ATTEND 
condition, vouchers were earned for attending clinics three times each week; in 
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the CM-MEDICATION condition, vouchers were earned for evidence of pill taking 
behavior through monitoring by Medication Event Monitoring Systems and tests 
to determine the presence of riboflavin (Schmitz et al., 2010). 
Previous research noted in this study supported the use of contingency 
management in reinforcing medication compliance such as with retroviral 
medications in HIV-positive methadone patients. This study examined six 
different treatment conditions: levodopa/carbidopa (800/200 mg/d) or placebo 
given in combination with one of three different behaviors noted earlier. In the 
CM-ATTEND condition, cash-valued vouchers were earned for attending clinic 
visits three times each week; in the CM-MEDICATION compliance condition, 
vouchers were earned contingent upon evidence of pill taking obtained by the 
number of electronic cap openings by Medication Event Monitoring Systems and 
evidence of riboflavin, administered at 100mg strength in the levodopa capsule. 
Vouchers were earned based on cocaine-negative urine results in the CM-
URINE condition. In addition to medication dosing on an escalating schedule until 
the final week of the study when dosing was reduced, subjects attended brief 
meetings conducted by nursing staff three days each week. A missed session 
could be rescheduled on an off day without penalty. A one-hour session that was 
led following a manual on cognitive-behavioral therapy was also required. A 
research assistant followed targeted behaviors and distributed vouchers each 
week. Voucher values started at $2.50, increasing by $1.25 for each consecutive 
occurrence of a targeted behavior. A $10 bonus voucher could be earned for 
evidence of three consecutive occurrences of a targeted behavior. Subjects were 
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given written documentation of earned vouchers and the coinciding dollar 
amount. Vouchers could be exchanged for gift certificates or for cash at any time 
during the trial. Total amount that could be earned was $997.50 over the 12-
week period (Schmitz et al., 2010). 
At the study’s half-way point, 51% of participants were continuing in the 
study and during the final week of the study, 35% remained with a higher 
retention level found in the CM-ATTEND condition. The study did not support the 
hypothesis that levodopa would enhance the effectiveness of contingency 
management rewards. “The observed lack of Levodopa versus placebo 
differences on CM effects for attendance and medication compliance outcomes 
fails to support a general reward enhancement explanation. That Levodopa 
enhanced responding only under the urine-based intervention suggests a more 
nuanced synergy between Levodopa and CM” (Schmitz et al., 2010, p. 242). 
The authors concluded, “While most CM interventions target abstinence 
outcomes, this study provides evidence of improved outcomes when targeting 
therapeutic goals of clinic attendance and medication compliance, consistent with 
previous reviews of CM effectiveness (Griffith et al., 2000; Lussier et al., 2006)” 
(Schmitz et al., 2010, p. 242). The study’s finding that higher voucher earnings 
were obtained in the CM condition that reinforced attendance meant that 
targeting this behavior gave participants more opportunities for contact with 
contingencies. The authors suggested shaping as a tool that could be used by 
successively increasing the task’s difficulty by beginning with CM reinforcement 
for clinic attendance, building on this behavior by adding medication compliance 
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as another targeted behavior and subsequently, the target behavior of 
abstinence (Schmitz et al., 2010). 
Study limitations noted by the authors were small sample size and a high 
attrition rate and added, “…although significant CM effects were found, actual 
rates of responding were less than robust, perhaps because of variations in the 
administration of the CM” (Schmitz et al., 2010, p. 243). Despite its limitations, 
authors concluded that the strengths of the study, specifically its design, allowed 
“testing of the independent and interactive effects of the treatment factors,” and 
that contingencies were “well-defined using objective measures of the target 
behavior” (Schmitz et al., 2010, p. 243). The study’s examination of the 
interaction of levodopa and abstinence-based contingency management could 
support a new approach for reward-based interventions that may successfully 
compete with the highly addictive reinforcing effects of cocaine (Schmitz  
et al., 2010). 
Results of a meta-analysis by Prendergast, Podus, Finney, Greenwell and 
Roll (2006) support the effectiveness of varied contingencies used during 
treatment for illicit drugs and other substances such as nicotine and alcohol. 
When contingencies are removed, targeted behaviors diminish slowly with time, 
yet individuals are able to benefit from treatment with contingencies. The authors 
caution that while drug users who are early in their use or for those who are not 
in full blown dependence, reinforcement for abstinence only, with fewer services 
and limited staff requirements may be effective for this population but the “limited 
data on effect sizes following CM suggest that continuing care is warranted” 
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(Prendergast et al., 2006, p. 1556) when using CM only with more dependent 
drug users. The authors acknowledge a large body of empirical studies exists 
regarding contingency management used with different drugs of abuse, a “high 
methodological quality of CM studies,” and the “relatively high mean effect size 
provide strong support for CM as being among the more effective approaches to 
promoting abstinence during and after the treatment of drug dependence 
disorders” (Prendergast et al. 2006, p.1556). Recommended future research, 
according to the authors, should include “examination of the relative 
effectiveness of different types of CM, further investigation of moderators of the 
impact of CM and comparison of the effects of CM and other treatment 
approaches” (Prendergast et al., 2006, p. 1556).  
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CHAPTER 5 
STAGES OF READINESS AND MOTIVATION FOR CHANGE 
 
In spite of the highly addictive properties of crack cocaine and other 
substances, change is possible but many times individuals enter treatment with 
ambivalence about changing their behaviors (Ramsey & Newman, 2000). In 
order for change to happen, the individual has to be ready to change. Frequently 
referenced in addiction literature is an empirical transtheoretical protocol 
consisting of five stages that define readiness for change (Prochaska, 
DiClemente & Norcross, 1992; Center for Substance Abuse Treatment, 1999; 
Bloom & Smith, 2001; Floyd & Seale, 2002; Edwards, Marshall & Cook, 2003). 
The five stages are not linear in construct but rather circular to account for 
the recycling that may occur by an individual through the various stages. The 
stages and the defining elements (Prochaska et al., 1992) are: 
1. Precontemplation: No intent to change; little insight about 
ramifications of substance use; if in treatment probably mandated 
by judicial system or by a significant other such as a spouse; 
procrastination common. 
2. Contemplation: More aware of problems caused by substance use 
and may consider actions to change but there is no commitment to 
a process of change; passively look at pros and cons of use; giving 
“lip service” to change. 
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3. Preparation: may take some steps to stop using such as reducing 
use or avoiding use at certain times; plan in place for change and 
state intention to start in near term. 
4. Action: Steps taken to achieve targeted goals; can show specific 
actions taken to alter addictive behavior with tangible results; feel 
hopeful and empowered but vulnerable to relapse at any point in 
time. 
5. Maintenance: engaged in lifestyle changes for more than six 
months; working on relapse prevention plan and solidifying 
treatment targeted goals. 
Individuals may move in and out of each stage. For example, an individual 
may move from the action phase into relapse and be precontemplative about 
changing or moving from relapse into a preparation stage that would allow 
removal of obstacles that precipitated relapse. By basing interventions on where 
the individual is in the change cycle, the therapist connects with the individual, 
avoiding antagonism and improving the likelihood of success (Floyd & Seale, 
2002).  
In the stages of change model, therapists strategize with the client, do not 
take on an authoritarian role and avoid confrontation. An atmosphere of 
cooperation is created with the goal of increasing “the intrinsic motivation,” and 
“leaving them with the responsibility to effect their own change” (Edwards et al., 
2003, p. 316). Early in the process, clients are helped to explore ambivalence 
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using client-centered counseling, including open-ended questions, reflective 
listening, affirmation, and summarizing (Edwards et al., 2003). 
Goldstein (1994) noted, that Prochaska’s model provides “ … a practical 
framework in the treatment setting” (Goldstein, 1994, p. 315). Clients in the 
precontemplation stage are able to change and those in the action stage may 
fail. Goldstein stated that the stages of change model is “over-simplified and 
artificial” and “despite its shortcomings, the ‘stages of change’ model is routinely 
used by clinicians in the alcohol and addictions field…” (Goldstein, 1994, p. 315). 
Giovazolias and Davis (2005) conducted a study following Prochaska’s 
model regarding matching appropriate therapeutic intervention according to the 
stage of readiness for change in addictive clients. A distinguishing characteristic 
of this study is that it focused specifically on the perspectives of individuals with 
drug and alcohol issues, examining a client’s view as to the most appropriate 
intervention in relation to their stage of readiness. The authors hypothesized that 
“clients in the early stages would consider non-action interventions to be 
significantly more helpful, while clients in the later stages would find action-
oriented interventions to be more beneficial for them” (Giovazolis & Davis, 2005, 
p. 175). 
Clients in the study had drug and/or alcohol problems and were recruited 
from an outpatient clinic within the National Health Service. Each participant 
received an information sheet, consent form, two questionnaires and a stamped 
addressed return envelope in which they were to return their questionnaire, either 
drug or alcohol, based on their perceived addiction issue.   
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The first questionnaire classified clients into one of the five stages of 
change based on their “…recent drinking or drug use, reported intention to 
change, and recent quit-change attempts”  (Giovazolis & Davis, 2005, p. 176). 
The second questionnaire, created by Giovazolis and Davis, included 
demographic characteristics and questions specific to their histories of previous 
treatment. Eight questions dealt with the type of therapy they thought would be 
most appropriate at present. Using a five-point Likert scale, clients were asked to 
indicate their degree of agreement or disagreement and the degree of 
helpfulness or usefulness of treatment. Four of the eight questions represented 
an “action-oriented, high structure counseling style, and four represented a non-
action, low structure facilitative approach” (Giovazolias & Davis, 2005,  
p. 176). On receipt, the anonymous questionnaires were numbered in the order 
they were received and were transferred to an SPSS statistical package for 
analysis (Giovazolias & Davis, 2005). 
Ninety-five completed questionnaires were turned in for a response rate of 
53%; 55 were male and 40 were female. The majority of respondents were 
between 31 and 40 years of age (21.1%), 62.1% reported drugs as their primary 
addiction problem and of those, 61% were males and 39% were females. 
Allocation of participants to the five stages of change were as follows: 14.7% in 
the precontemplative stage; 21.1% in the contemplation stage; 18.9% in the 
preparation stage, 20% in the action stage and 25.3% in the maintenance stage. 
Statistical analysis indicated significant differences in preferences, with those in 
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the early stages “showing a strong inclination to the non-action oriented 
interventions (p<.001)” (Giovazolias & Davis, 2005, p. 177).  
Outcomes of the study cited by the authors as being of interest were the 
finding that the majority, 64.2%, of respondents were in the later stages of 
readiness to change, which the author stated was logical since recruitment took 
place at Drug and Alcohol Services and participants should be in at least the 
contemplation stage of change because they had made the commitment to 
attempt treatment. By comparison, 14.6%, a relatively large percentage based on 
the sample size, were in the precontemplation phase, which was in agreement 
with findings from similar studies. The study’s finding that more men were in the 
earlier stages of change, while females were in the later stages, led the authors 
to speculate that “perhaps men are more reluctant than women to recognize, 
accept and seek help for their addictive problems” (Giovazolias & Davis, 2005, p. 
179). The other interesting outcome the authors noted was that participants in 
the earlier stages, irrespective of gender, “significantly prefer non-action oriented 
therapeutic interventions than action-oriented interventions (Giovazolias & Davis, 
2005, p. 179). 
According to the authors, of even greater interest was their finding that “no 
difference exists between those who had seen a therapist and those who did not 
have this experience, in terms of their preferred therapeutic interventions” 
(Giovazolias & Davis, 2005, p. 180). Rather than expecting a “magical solution” 
(Giovazolias & Davis, 2005, p. 180), those who had not experienced therapy 
were realistic about what would actually be of help to them. The study found a 
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higher correlation between stages and preferred therapeutic intervention for 
participants with drug addiction, “indicating that this group has a stronger 
tendency to prefer non-action interventions when they are in the ‘early’ stages, 
and action-oriented interventions when they are in the later stages of change” 
(Giovazolias & Davis, 2005, p. 180). The results of the study “indicate that there 
is a strong match between the theoretical predictions and the clients’ views on 
this issue. In other words, it seems that clients in the ‘early’ stages of change (i.e. 
Precontemplation, Contemplation), irrespective of gender or whether they had 
seen a therapist in the past, consider non-action oriented therapeutic 
interventions to be more beneficial for them, whereas clients in the ‘later’ stages 
of change (Preparation, Action, Maintenance) regard action-oriented 
interventions to be more helpful” (Giovazolias & Davis, 2005, p. 181). 
A therapeutic intervention that is useful in motivating clients through the 
stages of change is the Motivational Interview (MI), developed by William Miller, 
and referenced frequently in addiction literature (Peele & Brodsky, 1991; 
Substance Abuse and Mental Health Services, 1999; Miller & Rose, 2009). The 
technique “draws on strategies from client-centered counseling, cognitive 
therapy, systems theory and the social psychology of persuasion” (Peele & 
Brodsky, 1991, p.183). Related to the stages of change, motivational 
interviewing, set in an atmosphere of nonconfrontation, using “open-ended 
questions, reflective listening, affirmation and summarizing,” motivational 
interviewing helps the client to view the discrepancy between their behavior and 
their targeted goals. Motivational interviewing “develops and amplifies this 
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discrepancy, ultimately allowing the patient to present the reasons for change 
without feeling coerced” (Peele & Brodsky, 1991, p. 183). 
Interestingly, Miller’s technique came from an unexpected finding after 
Miller trained nine counselors in behavioral self-control training and accurate 
empathy. Three supervisors observed the trained counselors using these 
techniques, using a rank ordering as to the extent the counselors used 
empathetic understanding during therapy. At six, 12 and 24 months post-
treatment, counselor empathy accounted for statistically significant outcomes for 
therapist style and not for the behavioral interventions being compared and later 
research by others confirmed this finding (Miller & Rose, 2009). 
 “A guiding principle of MI was to have the client, rather than the 
counselor, voice the arguments for change” (Miller & Rose, 2009, p. 528). 
Motivational interviewing was incorporated into different models of treatment by 
Miller and others. Three clinical trials (Miller and Brown, 1993) randomly 
assigned participants in each trial into one of two groups: one MI session at the 
onset of treatment or no MI session at the start of treatment. In all trials, 
participants who received the MI session at outset of treatment showed “double 
the rate of total abstinence three to six months after inpatient treatment” (Miller & 
Rose, 2009, p. 528). 
With more than 200 clinical trials published and efficacy reviews and 
meta-analyses conducted, MI has found positive outcomes in trials conducted on 
cardiovascular rehabilitation, diabetes management, problem gambling, and 
others in addition to substance use. Multi-site trials have been conducted using a 
45 
 
 
form of MI that combines MI with motivational enhancement therapy (MET). MET 
is defined in a study conducted by Lawendowski (1998): “Motivational 
Enhancement Therapy (MET) embeds MI within a structured format of 
standardized intake assessment, personalized feedback of test results, and 
follow-up interview to facilitate treatment outcome evaluation” (Lawendowski, 
1998, p. A39). 
The first multi-site trial of MET was Project MATCH, a nine-site trial with 
1,726 clients. “Outcomes through three years of follow-up were found to be 
similar for a four-session MET and two 12-session treatment methods with which 
it was compared, yielding a cost-effectiveness advantage for MET” (Miller & 
Rose, 2009, p. 529). However, Miller and Rose (2009) noted that not all trials 
yielded positive results. Citing other studies, null findings were reported with 
eating disorders, drug abuse and dependence, smoking, and problem drinking. 
Clinician delivery of MI is a factor and not all participants respond positively to 
MI-based therapy, and efficacy of MI may vary across populations, which 
account for some of the null findings in trials. The authors stated, “Such variability 
in outcomes across and within studies suggests the need to understand when 
and how a treatment works and the conditions of delivery that may affect its 
efficacy” (Miller & Rose, 2009, p.529). 
While the authors raised some of concerns with MI such as the 
relationship between therapist responses, client speech and subsequent 
behavior change, discovering how therapist empathy actually affects client 
outcomes and determining relational and technical components of MI, after 30 
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years of research, “motivational interviewing is a psychotherapeutic model that is 
evidence-based, relatively brief, specifiable, applicable across a wide variety of 
problem areas, complementary to other active treatment methods, and learnable 
by a broad range of helping professionals” (Miller & Rose, 2009, p. 535). 
Using MI and/or MET provides an atmosphere that encourages individuals 
in drug abuse treatment to look at the disconnect between where he or she is in 
the stage of change continuum and to work toward targeted behavioral goals that 
are achievable. The cookie cutter or one size fits all mentality that has been used 
so often in treatment modalities is no longer refutable as a valid methodology for 
successful treatment outcomes. A study conducted by Rohsenow, Monti, Martin, 
Colby, Myers, Gulliver, Brown, Mueller, Gordon and Abrams (2004) provided 
additional evidence of the effectiveness of MET. The study recruited 165 
cocaine-dependent clients enrolled in daily substance abuse treatment in a 
hospital setting that focused on learning theory and the 12-Step philosophy. The 
study provided two sessions for cocaine-specific MET or a control condition of 
meditation relaxation treatment (MRT) only during the first three days of a 
treatment substance abuse treatment program. Patients met cocaine 
dependence criteria according to the Structured Clinical Interview for DSM-IV, 
patient version (1995) and to have used cocaine at least 10 days during the six 
months before admission. Actively psychotic individuals and those who planned 
to stay less than five weekdays were excluded from the study. Informed consent 
forms were completed on the second day of the study and assessments were 
done following recruitment, at discharge and again at three, six and 12 months 
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post-discharge. Treatments consisted of 50-minute sessions every day, “with 
individual sessions for two days followed by group sessions on subsequent days. 
The study treatments replaced the program’s groups on functional analysis and 
relapse prevention. Patients attended all other program activities (Rohsenow et 
al., 2004, p. 864). 
Using a Timeline Followback interview, which was given for six months 
before treatment began and at each follow-up, assessed number of days of 
cocaine, alcohol and other drug use and at every follow-up, urine specimens 
were collected to determine drug use and a close friend or family member was 
interviewed to corroborate the patient’s drug use or abstinence during this period. 
“The Addiction Severity Index, 5th edition (ASI), which was given at pre-treatment 
and at every follow-up was scored for the composite indices. For MET feedback, 
some questions were repeated adding ‘as a result of your cocaine use’ 
(Rohsenow et al., 2004, p. 864). 
For MET feedback, additional measures were completed by all patients 
before randomization into the two study groups:  Cocaine Effects Questionnaire 
for Patient Populations, Cocaine Negative Consequences Checklist, Arithmetic 
subtest of the Wechsler Adult Intelligence Scale-Revised, Logical Memory Test 
of the Wechsler Memory Scale and Symbol Digit Modalities Test in addition to a 
checklist of 10 medical consequences of cocaine, 12 route-specific 
consequences, five pregnancy/fetal effects and four accident risk items were 
administered. AIDS risk comprised 33 items regarding frequency of cocaine-
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related risky sexual behavior and risky drug use practices during the previous 30 
days from the Risk Behavior Assessment (Rohsenow et al., 2004). 
For MET, the initial session dealt with the patient’s understanding of the 
pros and cons of their cocaine use, quitting cocaine, life goals and how cocaine 
impacts achieving those goals, and their life one and 10 years from that point 
with and without cocaine use. The second session reviewed their assessment 
feedback as follows: “cocaine use relative to norms for cocaine abusers in 
treatment and legal outcome, consequences identified by cocaine-modified ASI 
questions and Cocaine Effects Questionnaire, neuropsychological functioning 
(presented as five-point scales from well below average to well above average), 
accident risk due to cocaine, medical complications from intoxication, withdrawal, 
route, pregnancy and ASI items, and AIDS risk resulting from cocaine use. The 
session closed with a summary, elicited reactions, built hope for improvement 
through cessation, provided help with decision making and reinforced self-
efficacy” (Rohsenow et al., 2004, p. 865-866). 
MRT was selected because relaxation training is commonly used in 
substance abuse treatment even though there is no scientific evidence to prove it 
is effective with changing substance use. During the first minutes of each 
session, patients were taught to focus on sensations such as warmth and 
heaviness in each body part. Without interrupting the physical relaxation 
sensation, patients were told to visualize a pleasing scene that did not include 
drug use (Rohsenow et al., 2004). 
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Following statistical analysis of the groups, it was found that “MET had 
several beneficial treatment effects when provided at the start of an intensive 
substance abuse treatment program for cocaine dependent patients, particularly 
for those low in initial motivation to change cocaine use. Although low pre-
treatment motivation in the contrast condition predicted higher relapse to cocaine 
in the first 3 months, patients in MET with low initial motivation reported lower 
rates of relapse to alcohol at 4-6 months, less relapse to cocaine and alcohol at 1 
year follow-up, fewer cocaine and alcohol use days during the year and less 
sever alcohol problems than patients in MET with higher initial motivation to 
change. Thus, MET appears to be more beneficial for less motivated patients 
than for more motivated patients. Also, there was a significant time x treatment 
interaction for employment problems; patients in MET tended to report a 
decreasing severity of employment problems over the year of follow-up while 
contrast patients did not” (Rohsenow et al, 2004, p. 872).  
Statistical analyses were conducted to assess effects of individual 
treatment with MET versus MRT and across other variables such as scoring on 
the various instruments administered across the study. “An ANOVA showed 
higher effectiveness rating for MET (M=6.2 ± 1.1) than MRT (M=5.8 ± 1.2), 
F1.139=3.85, P<0.005, f=0.17 (small)” (Rohsenow et al., 2004, p. 871). 
Despite study limitations, which included sample size, attrition, using a 
private substance abuse program rather than a community based program and 
using an intensive program versus less intensive outpatient programs, the 
authors concluded that “programs that provide MET should probably provide it 
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only to patients who are less motivated to change” and that “promise was shown 
for the value of two sessions of MET early in treatment for cocaine abusers . . .” 
(Rohsenow et al., 2004, p. 872). 
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CHAPTER 6 
                                  FINDING ALTERNATE BEHAVIORS 
 
Finding alternate behaviors when abstinence from one or more drugs is 
achieved is paramount to prevent relapse. Moos (2006) noted, “Behavioral 
economics or behavioral choice theory, which is closely related to the social 
control perspective, focuses specifically on involvement in protective activities. In 
behavioral choice theory the key element of the social context is the alternative 
reinforcements provided by activities other than substance abuse. These 
alternative reinforcements can protect individuals from exposure to substances 
and opportunities to use them, as well as from escalating and maintaining 
substance use. The theory posits that the choice of one reinforcing before, such 
as substance use, depends in part on lack of effective access to alternative 
reinforcements, such as involvement in school and work pursuits, religious 
engagement, and participation in physical activity. For example, physical activity 
and substance use may both elevate mood and decrease anxiety, which make 
them functionally similar and substitutable” (Moos, 2006, p. 183). 
Two behaviors frequently recommended to take the place of drug using 
behavior are exercise and relaxation training (Urschell, 2009; Prentiss, 2007; 
Peele & Brodsky, 1991; Bilodeau, 1992; Ratey, 2008). While both behaviors 
have been proven as viable alternatives to drug using behaviors, this review will 
focus on behavioral relaxation. Poppen (1988), following up on Edmund 
Jacobsen’s original progressive relaxation model, posited a Behavioral 
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Relaxation Scale (BRS) in order to measure relaxation to determine treatment 
outcomes.  
The BRS consists of ten postures and their coordinating observable 
“relaxed” and “unrelaxed” states. The areas targeted for relaxation are: head, 
eyes, mouth, throat, shoulders, body, hands, feet, quiet, and breathing. Poppen 
noted, “The BRS has been shown to change in the expected direction when 
people undergo relaxation training in the motoric domain, namely progressive 
relaxation training (BRT), frontalis EMG biofeedback, and, of course BRT” 
(Poppen, 1988, p. 45). 
Depressive disorder is a common diagnosis with drug use. Whether it is 
present prior to drug abuse or is a by-product of withdrawal from drug use, 
depression and substance use often occur concurrently. Carpenter, Smith, 
Ahdronovich and Nunes (2008) noted, “The relationship between environmental 
contingencies and the course of depression and substance abuse suggests that 
targeting environmental factors may be a particularly useful strategy for 
simultaneously treating both disorders” (Carpenter, et al. 2008, p. 643). A 
randomized trial of Behavioral Therapy for Depression in Drug Dependence 
(BTDD) was compared to an attention control with Relaxation Therapy (REL) 
selected as the control condition (Carpenter et al., 2008). 
Of the 126 methadone-maintained opiate dependent candidates assessed 
for inclusion in the study, 38 were accepted based on study inclusion criteria, 
which included administration of the Structured Clinical Interview for DSM-IV 
Substance Abuse Comorbidity, “current DSM-IV Major Depression or Dysthymic 
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Disorder and a stable methadone dose (no changes in the prior two weeks) of 60 
mg or greater; lower methadone doses were allowed if part of a slow methadone 
taper following a successful maintenance period” (Carpenter et al., 2008, p. 643), 
and completion of consent forms.  
Depression severity was assessed at baseline and at the start of each 
weekly session by one of the study’s trained and experienced clinicians using the 
29-item Hamilton Depression Scale. Participants rated their depression using the 
21-item Beck Depression Inventory II at baseline and bi-weekly during treatment.    
At the beginning of each session, a clinician administered the Substance 
Use Weekly Inventory to ascertain the number of days that opiates, cocaine, 
alcohol, cannabis, sedative-hypnotics, stimulants and other substances were 
used since the participant’s last session. Urine samples were collected weekly 
under observation by a study staff member and were tested for opiates, cocaine 
and benzodiazepines. Of the 533 urine samples collected, 370 had 
corresponding self-reports for use the prior week; of those 370, “agreement 
between toxicology results and self-reported use was 89% for opiates, 95% for 
cocaine, and 94% for benzodiazepines” (Carpenter et al., 2008). 
Participants were randomized to either one of two treatment conditions: 
BTDD or REL stratified by antidepressant use at the time of study entry and illicit 
drug use during the week prior to the start of the study. The BTDD section used 
three operant-based treatments: changing reinforcement events, community 
reinforcement approach and treatment plan contingency management program.  
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BTDD was administered over 24-weekly sessions and clinicians used a 
structured treatment guide. Activities focused on improving the number and 
quality of interactions participants experienced with their environments. At weekly 
sessions, participants “defined objectively verifiable out-of-session activities to 
increase the amount of pleasant activities in specified life areas” (Carpenter et 
al., 2008, p. 645).  
A Treatment Plan Contingency Management system was implemented 
that gave points for actively participating in sessions (three points) and 
completing out-of-session homework (10 points). Verification of out-of-session 
homework was required by submitting movie ticket stubs, etc., and activities were 
agreed to during the previous week’s session.  
A total of 208 points were possible for 100% attendance (72 points) and 
completion of all out-of-session homework (136 points). Voucher points equated 
one dollar for each point and could be exchanged for goods and services 
selected by the participant and in sync with treatment goals (Carpenter et al., 
2008). 
REL was given across the 24-weekly sessions using a training manual. 
REL incorporated four areas constituting successful therapies for depression: “a 
clear rationale for treatment, provision of skills to help individuals become more 
effective in handling his/her life, an emphasis on the use of these skills outside of 
the therapy context, and reinforcing therapy success to use these skills” 
(Carpenter et al., 2008, p. 645).  
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The three relaxation methods covered were: progressive muscle 
relaxation, autogenic relaxation exercises and visual imagery based on 
idiographic scenarios of relaxation or tranquility. Participants used the techniques 
during weekly sessions and were encouraged to track depression/anxiety during 
the week and use relaxation exercises. All participants were told they could begin 
taking medication if depression significantly worsened or they felt they had not 
improved after six weeks of treatment.  
Clinicians completed a BTDD or Relaxation Therapy Checklist, which 
contained key areas of each treatment and how to access adherence to each 
therapy condition, following every session (Carpenter et al., 2008). 
The average depression ratings at the study’s end indicated a significant 
decrease in self-reported and clinician rated depression during treatment; 
however, the rate of change did not differ between treatment conditions. 
Participants in BTDD earned approximately one-third of the maximum number of 
voucher points that could be received. Among participants who received BTDD, 
there was a significant increase in the probability of opiate use during treatment 
after adjusting for adjunctive pharmacotherapy.  
The significant reduction in depressive systems observed in both the 
BTDD and REL conditions “supports the possible utility of both treatment 
strategies in this population and suggests possible avenues for the continued 
refinement of a behaviorally based treatment program for depression and 
comorbid substance use in a methadone-maintained population” (Carpenter et 
al., 2008., p. 649). The authors noted, “Relaxation training may offer an important 
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therapeutic technique for treating depression among dually-diagnosed patients. 
The acceptability of the treatment suggests that incorporating these techniques in 
a comprehensive program may promote better attendance and engagement 
compared to more demanding behavioral interventions” (Carpenter et al., 2008., 
p. 649).  
Contingency management, however, may have been affected by the 
presence of a depressive disorder and the authors concluded that vouchers “of a 
larger magnitude that target both abstinence and treatment plan activities may 
increase the effectiveness of this strategy for treating both depression and 
comorbid substance use” (Carpenter et al., 2008, p. 650) and “focusing on 
avoidance behaviors and placing change in the broader context of valued life 
goals may provide a better strategy than focusing solely on increasing pleasant 
activities” (Carpenter et al., 2008, p. 650). 
The authors recognized several study limitations: small sample size and 
significant attrition rate limited the power to detect group differences and 
restricted generalizability to other populations; no control condition eliminated 
equating the benefits of the study’s treatment conditions to the no treatment 
condition; the BTDD condition had a higher proportion of opiate users, which may 
have reduced the efficacy of BTDD relative to REL and could explain the 
increase of opiate use over the course of the trial for BTDD participants 
(Carpenter et al., 2008). 
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           CHAPTER 7 
IS A “CURE” POSSIBLE? 
 
Based on the research literature reviewed regarding drug addiction, there 
is no “cure” per se, no magic bullet, no easy out. Drug addiction is a life-long 
condition that may be managed through a willful dedication to change the 
behaviors that resulted in dependence on crack cocaine or other substances. 
Ongoing research, as presented here, is promising because it is evidence-based, 
which makes it plausible as a viable avenue for change.  Brain research, 
particularly that which examines the chemical circuitry involved in naturally 
occurring rewards and how drugs short-circuit and shutdown pathways, alters 
cell content and consequently the ability to decide against drug taking behaviors, 
is encouraging. 
What if a vaccine were available, similar to measles or tetanus 
vaccinations, that could eliminate the negative repercussions associated with 
drug dependence? Anti-drug vaccines could train the immune system to destroy 
a drug like cocaine before it reached the brain. But the brain does not operate 
alone. “To accept the proposition of an addict’s powerlessness is to eliminate 
volition from the equation, for we know from hard evidence that addicts can and 
do kick the habit. And, no matter how difficult it eventually becomes to exercise 
choice, there is always a period at the outset when choice is not only possible but 
relatively easy,” according to Rosenthal (Rosenthal, 2008, p.43). 
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In spite of its detractors, immunology studies are ongoing. To be effective, 
anti-drug vaccines used to thwart the major drugs of abuse – nicotine, heroin, 
cocaine and methamphetamine, need to produce “a high concentration of 
antibodies with high affinity for the drug, would bind the drug molecule in the 
circulation and prevent it from crossing the blood-brain barrier and accessing its 
receptor in the brain” (Kinsey, Jackson & Orson, 2009, p. 309).  
Thus far, anti-drug vaccines have shown promise when used in rodents, 
“both in terms of the concentration of antibodies elicited by the vaccine and in the 
reduction of drug associated behavior shown by vaccinated animals when 
challenged with the drug” (Kinsey et al., 2009, p. 309).   
A vaccine that would prevent cocaine from reaching the brain would be 
beneficial in conjunction with behavior analysis and therapy. According to Kinsey 
et al. (2009), the vaccine should have “few side effects, and should elicit high 
levels of antibodies of good affinity after a reasonable delivery schedule” (Kinsey 
et al., 2009, p. 311). The authors noted, “The approximate concentration of 
cocaine in the blood after a session of smoking crack, for example, is well known, 
and the concentration of anti-cocaine antibodies in vaccinated individuals is also 
known. Comparing those numbers makes it evident that a person determined to 
get a high from cocaine could easily just take more. That is why it is so essential 
that anti-cocaine vaccination be accompanied by other forms of intervention, 
such as drug counseling, to achieve a successful outcome for the addict” (Kinsey 
et al., 2009, p. 311). 
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Peterson and Owens (2009) reviewed research on the development of an 
anti-drug vaccine for methamphetamine addiction. Like the Kinsey, et al, 
research referenced above, the authors concurred that a vaccine alone is not the 
answer. “Results from preclinical and clinical studies of active and passive 
vaccines against drugs of abuse show promise as a viable medical approach to 
treat addiction. However, antibody antagonists are not intended to be used as a 
standalone ‘magic bullet’ to cure drug abuse. Similar to insulin treatment for 
diabetic patients, they are likely best used in combination with a long-term 
comprehensive medical approach. Thus, the next critical steps are to optimize 
the therapeutic potential and timing of active or passive immunizations and to 
couple these with a behavioral modification program aimed at helping patients 
relearn constructive behaviors, impulse control, and resistance to the craving for 
the drug” (Peterson & Owens, 1999, p. 122). 
59 
 
CHAPTER 8 
AT WHAT COST? 
 
I loved the feeling of doing coke and heroin in a restaurant 
bathroom because it was so sneaky. I had to walk into the 
restaurant without anyone noticing, do my drugs, and walk out 
again without getting caught. I loved the risk, the hidden identity 
that I held, and the secret I was hiding. It made me feel a little like 
James Bond. 
(Prentiss, 2007, p. 108).  
A study conducted by the RAND Corporation in 2005 estimated the cost to 
the public for stimulant abuse to be $23 billion (Peterson & Owens, 2009). The 
U.S. Department of Justice, National Drug Intelligence Center, National Drug 
Threat Assessment 2010 (February 2010), reported, “The trafficking and abuse 
of drugs in the United States affect nearly every aspect of our lives. The 
economic cost alone is immense, estimated at nearly $215 billion. The damage 
caused by drug abuse and addiction is reflected in an overburdened justice 
system, a strained healthcare system, lost productivity, and environmental 
destruction” (National Drug Threat Assessment, 2010). 
Statistics supporting the payout of drugs from the National Drug Threat 
Assessment referenced above follow: 
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 In 2008, approximately 2.9 million individuals tried an illicit drug or 
used a prescription drug nonmedically for the first time, 
representing 8,000 initiates per day.  
 In 2008, approximately 7 million individuals aged 12 and older were 
dependent on or had abused illicit drugs in the past year, compared 
with 6.9 million in 2007. The drugs with the highest dependence or 
abuse levels were marijuana, prescription pain relievers, and 
cocaine. 
 In 2006, the Drug Abuse Warning Network (DAWN) reported that of 
113 million hospital ED visits, 1,742, 887 were related to drug 
misuse or drug abuse. When drug misuse or abuse is reported in 
ED visits, the most commonly reported substances are cocaine, 
marijuana, heroin, and stimulants. 
 Due to drug abuse/dependence, in 2007, there were approximately 
1.8 million admissions to state-licensed treatment facilities for illicit 
drug use/dependence, meaning they were not gainfully employed. 
In addition, in 2008 19.6% of unemployed adults were defined as 
current users of illicit drugs; 8% of individuals employed full time 
and 10.2% of individuals employed part-time were current users of 
illicit drugs. People who are employed but have chronic 
absenteeism from illicit drug use/abuse also have substantial lost 
productivity. 
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 In 2009, in California alone, the California Department of Toxic 
Substance Control responded to and cleaned up 232 laboratories 
and dumpsites at a cost of $776,889 or roughly $3,349 per site. 
According to the Office of National Drug Control Policy, Drug Policy 
Information Clearing House regarding Illinois statistics: 
 In 2002, there were 977 Illinois drug arrests by the Drug 
Enforcement Administration (DEA).  
 As of June 2005, approximately 25% of adult inmates in Illinois 
were detained or incarcerated for drug offenses.  
 In 2006, there were 996 drug arrests by the DEA and 112,368 state 
and local (Chicago area) drug arrests.  
 In 2006, it was reported that drug trafficking organizations based in 
Mexico routinely transported metric ton quantities of cocaine into 
Illinois, mainly Chicago.  
 During 2006, 41% of Federally-sentenced defendants in Illinois had 
committed a drug offense, of which one-third involved powder 
cocaine.  
 During 2006, there were 67,392 drug/alcohol treatment admissions 
in Illinois.  
  As of April 2007, there were 20 drug courts in Illinois with eight 
more planned for the near-term. As of 2009, there were 2,038 
active drug court programs throughout the U.S. and 226 were in 
the planning stages.  
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Currently, the focus of the nation is not on the impact of drug dependence 
on the economy, on our judicial and penal systems, on our healthcare system, on 
treatment modalities that are more frequently unsuccessful than successful, on 
the devastation to families who love someone addicted to drugs, etc.  
An interesting, but unscientific, experiment is to ask co-workers, friends, 
and acquaintances if they know anyone who is struggling with an addiction, not 
including nicotine or caffeine. You may be surprised to find that the majority of 
the people you query answer “yes.” Chances are they will relate experiences of 
frustration, helplessness, and despair in trying to find a resolution to their friend 
or loved one’s addiction.  
It is true that there is no “magic bullet” to erase addiction from our human 
condition. There has to be a concerted effort to change the tide of drugs coming 
into the country and to address how illicit drugs work in our economy, from 
providing a livelihood to pawnshop owners to corruption in law enforcement.  
It will not be easy. It will take families of addicts who have lost their battle 
with drugs to stand up and demand change. And to be strong enough to “tell it 
like it is” to everyone who will listen. To stop being embarrassed or ashamed to 
talk about the addiction of a son or daughter, husband or wife, mother or father.  
It will take a grassroots movement similar to Mothers Against Drunk Drivers to 
raise awareness about the waste of even one life to drugs.  
There is significant evidence-based research, some of which has been 
discussed in this paper, supporting substance abuse treatments that actually 
may change the path of someone addicted to a substance. Addiction treatment 
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professionals must start, if they do not already, to become familiar with this body 
of research and additional studies and incorporate methodologies into their 
practices. Treatment facilities have to be made accountable for the programs 
provided and should be mandated to produce outcome statistics that are 
reviewed by their board of directors and contributors and are part of staff 
performance evaluations. Perhaps one way to instigate change would be to 
include the costs associated with drug abuse and dependence in the country to 
every tax payer in the U.S. 
The question is who is going to start the revolution for change? 
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